Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry

Ichiro Murakami, Takashi Oka, Satoshi Kuwamoto, Masako Kato, Kazuhiko Hayashi, Jean Gogusev, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Tadashi Yoshino

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Langerhans cell histiocytosis (LCH) is a proliferative disorder of Langerhans cell (LC)-like CD1a-positive cell (LCH cell) with unknown causes. LCH consists of two subtypes: single-system LCH (LCH-SS) with favorable prognosis and multisystem LCH (LCH-MS) with poor prognosis. LCH has been indicated as a neoplastic disorder from monoclonal characteristics of LCH cells. This study aimed to investigate an expression of tyrosine phosphatase SHP-1 in LCH, since its expression levels were variously reported in many tumors, overexpression in ovarian cancers (a candidate oncoprotein), and downregulation by methylation in gastric cancers, prostate cancers, malignant lymphomas, and leukemias (a putative tumor suppressor). By immunohistochemistry (IHC), the SHP-1 expression in LCs and LCH cells was compared in LCH (two subtypes: LCH-SS=21, LCH-MS=12), dermatopathic lymphadenopathy (DLA) (n=9) and normal epidermal LCs (n=3) near LCH lesion. IHC results were analyzed semiquantitatively using a Photoshop software. The mean intensity score (IS) of DLA, LCH-SS, LCH-MS, and LCs were 47, 100, 139, and 167 (in arbitrary unit), respectively. The IS had significant differences among LCH-SS, LCH-MS, and DLA (p

Original languageEnglish
Pages (from-to)227-234
Number of pages8
JournalVirchows Archiv
Volume459
Issue number2
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Non-Receptor Type 6 Protein Tyrosine Phosphatase
Langerhans Cell Histiocytosis
Immunohistochemistry
Prostatic Neoplasms

Keywords

  • Immunohistochemistry
  • Langerhans cell histiocytosis
  • Photoshop-assisted image analysis
  • Staining intensity
  • Tyrosine-protein phosphatase nonreceptor type 6 (PTPN6, SHP-1)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology

Cite this

Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry. / Murakami, Ichiro; Oka, Takashi; Kuwamoto, Satoshi; Kato, Masako; Hayashi, Kazuhiko; Gogusev, Jean; Imamura, Toshihiko; Morimoto, Akira; Imashuku, Shinsaku; Yoshino, Tadashi.

In: Virchows Archiv, Vol. 459, No. 2, 08.2011, p. 227-234.

Research output: Contribution to journalArticle

Murakami, Ichiro ; Oka, Takashi ; Kuwamoto, Satoshi ; Kato, Masako ; Hayashi, Kazuhiko ; Gogusev, Jean ; Imamura, Toshihiko ; Morimoto, Akira ; Imashuku, Shinsaku ; Yoshino, Tadashi. / Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry. In: Virchows Archiv. 2011 ; Vol. 459, No. 2. pp. 227-234.
@article{8ac97f2314d84c37a856074fb1d20c36,
title = "Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry",
abstract = "Langerhans cell histiocytosis (LCH) is a proliferative disorder of Langerhans cell (LC)-like CD1a-positive cell (LCH cell) with unknown causes. LCH consists of two subtypes: single-system LCH (LCH-SS) with favorable prognosis and multisystem LCH (LCH-MS) with poor prognosis. LCH has been indicated as a neoplastic disorder from monoclonal characteristics of LCH cells. This study aimed to investigate an expression of tyrosine phosphatase SHP-1 in LCH, since its expression levels were variously reported in many tumors, overexpression in ovarian cancers (a candidate oncoprotein), and downregulation by methylation in gastric cancers, prostate cancers, malignant lymphomas, and leukemias (a putative tumor suppressor). By immunohistochemistry (IHC), the SHP-1 expression in LCs and LCH cells was compared in LCH (two subtypes: LCH-SS=21, LCH-MS=12), dermatopathic lymphadenopathy (DLA) (n=9) and normal epidermal LCs (n=3) near LCH lesion. IHC results were analyzed semiquantitatively using a Photoshop software. The mean intensity score (IS) of DLA, LCH-SS, LCH-MS, and LCs were 47, 100, 139, and 167 (in arbitrary unit), respectively. The IS had significant differences among LCH-SS, LCH-MS, and DLA (p",
keywords = "Immunohistochemistry, Langerhans cell histiocytosis, Photoshop-assisted image analysis, Staining intensity, Tyrosine-protein phosphatase nonreceptor type 6 (PTPN6, SHP-1)",
author = "Ichiro Murakami and Takashi Oka and Satoshi Kuwamoto and Masako Kato and Kazuhiko Hayashi and Jean Gogusev and Toshihiko Imamura and Akira Morimoto and Shinsaku Imashuku and Tadashi Yoshino",
year = "2011",
month = "8",
doi = "10.1007/s00428-011-1090-1",
language = "English",
volume = "459",
pages = "227--234",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry

AU - Murakami, Ichiro

AU - Oka, Takashi

AU - Kuwamoto, Satoshi

AU - Kato, Masako

AU - Hayashi, Kazuhiko

AU - Gogusev, Jean

AU - Imamura, Toshihiko

AU - Morimoto, Akira

AU - Imashuku, Shinsaku

AU - Yoshino, Tadashi

PY - 2011/8

Y1 - 2011/8

N2 - Langerhans cell histiocytosis (LCH) is a proliferative disorder of Langerhans cell (LC)-like CD1a-positive cell (LCH cell) with unknown causes. LCH consists of two subtypes: single-system LCH (LCH-SS) with favorable prognosis and multisystem LCH (LCH-MS) with poor prognosis. LCH has been indicated as a neoplastic disorder from monoclonal characteristics of LCH cells. This study aimed to investigate an expression of tyrosine phosphatase SHP-1 in LCH, since its expression levels were variously reported in many tumors, overexpression in ovarian cancers (a candidate oncoprotein), and downregulation by methylation in gastric cancers, prostate cancers, malignant lymphomas, and leukemias (a putative tumor suppressor). By immunohistochemistry (IHC), the SHP-1 expression in LCs and LCH cells was compared in LCH (two subtypes: LCH-SS=21, LCH-MS=12), dermatopathic lymphadenopathy (DLA) (n=9) and normal epidermal LCs (n=3) near LCH lesion. IHC results were analyzed semiquantitatively using a Photoshop software. The mean intensity score (IS) of DLA, LCH-SS, LCH-MS, and LCs were 47, 100, 139, and 167 (in arbitrary unit), respectively. The IS had significant differences among LCH-SS, LCH-MS, and DLA (p

AB - Langerhans cell histiocytosis (LCH) is a proliferative disorder of Langerhans cell (LC)-like CD1a-positive cell (LCH cell) with unknown causes. LCH consists of two subtypes: single-system LCH (LCH-SS) with favorable prognosis and multisystem LCH (LCH-MS) with poor prognosis. LCH has been indicated as a neoplastic disorder from monoclonal characteristics of LCH cells. This study aimed to investigate an expression of tyrosine phosphatase SHP-1 in LCH, since its expression levels were variously reported in many tumors, overexpression in ovarian cancers (a candidate oncoprotein), and downregulation by methylation in gastric cancers, prostate cancers, malignant lymphomas, and leukemias (a putative tumor suppressor). By immunohistochemistry (IHC), the SHP-1 expression in LCs and LCH cells was compared in LCH (two subtypes: LCH-SS=21, LCH-MS=12), dermatopathic lymphadenopathy (DLA) (n=9) and normal epidermal LCs (n=3) near LCH lesion. IHC results were analyzed semiquantitatively using a Photoshop software. The mean intensity score (IS) of DLA, LCH-SS, LCH-MS, and LCs were 47, 100, 139, and 167 (in arbitrary unit), respectively. The IS had significant differences among LCH-SS, LCH-MS, and DLA (p

KW - Immunohistochemistry

KW - Langerhans cell histiocytosis

KW - Photoshop-assisted image analysis

KW - Staining intensity

KW - Tyrosine-protein phosphatase nonreceptor type 6 (PTPN6, SHP-1)

UR - http://www.scopus.com/inward/record.url?scp=80052414117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052414117&partnerID=8YFLogxK

U2 - 10.1007/s00428-011-1090-1

DO - 10.1007/s00428-011-1090-1

M3 - Article

C2 - 21604205

AN - SCOPUS:80052414117

VL - 459

SP - 227

EP - 234

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 2

ER -